Vincent Planche
Maitre de Conférence - Praticien hospitalier
MCU PH / Université de Bordeaux / CHU/ Contact
+33 5 33 51 47 19
www.orcid.org/0000-0003-3713-227X
Publications
-
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
JAMA Neurol. 2024-11-01.
10.1001/jamaneurol.2024.3770 -
Development and assessment of algorithms for predicting brain amyloid positivity in a population without dementia
Alz Res Therapy. 2024-10-11. 16(1)
10.1186/s13195-024-01595-5 -
Disentangling clinical and biological trajectories of neurodegenerative diseases
Nat Rev Neurol. 2024-08-08.
10.1038/s41582-024-01004-3 -
Dynamic Evolution of Infarct Volumes at MRI in Ischemic Stroke Due to Large Vessel Occlusion
Neurology. 2024-06-01. 102(12)
10.1212/wnl.0000000000209427 -
Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis
Neurol Neuroimmunol Neuroinflamm. 2024-05-01. 11(3)
10.1212/NXI.0000000000200222 -
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening
Genetics in Medicine. 2024-05-01. 26(5) : 101082.
10.1016/j.gim.2024.101082 -
Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan
Brain Communications. 2024-01-01. 6(2)
10.1093/braincomms/fcae055 -
Tau seeds from Alzheimer’s disease brains trigger tau spread in macaques while oligomeric‐Aβ mediates pathology maturation
Alzheimer's & Dementia. 2023-12-26.
10.1002/alz.13604 -
Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories
Alz Res Therapy. 2023-11-22. 15(1)
10.1186/s13195-023-01348-w -
Deep grading for MRI-based differential diagnosis of Alzheimer’s disease and Frontotemporal dementia
Artificial Intelligence in Medicine. 2023-10-01. 144 : 102636.
10.1016/j.artmed.2023.102636 -
Lifespan neurodegeneration of the human brain in multiple sclerosis
Human Brain Mapping. 2023-08-24.
10.1002/hbm.26464 -
Mnemonic Discrimination Performance in a Memory Clinic: A Pilot Study
JAD. 2023-07-10. : 1-8.
10.3233/jad-230221 -
Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort
Alzheimer's & Dementia. 2023-07-08.
10.1002/alz.13360 -
Delirium, blood biomarkers for neurodegeneration, and dementia
The Lancet Healthy Longevity. 2023-07-01.
10.1016/s2666-7568(23)00104-6 -
Advocating for Demonstration of Disease Modification—Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?
JAMA Neurol. 2023-04-24.
10.1001/jamaneurol.2023.0815 -
Anatomical MRI staging of frontotemporal dementia variants
Alzheimer's & Dementia. 2023-02-07.
10.1002/alz.12975 -
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease
Brain Communications. 2023-01-01. 5(3)
10.1093/braincomms/fcad175 -
Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort
Alzheimer's & Dementia. 2022-12-04.
10.1002/alz.12866 -
Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates
Brain. 2022-11-16.
10.1093/brain/awac428 -
High-clearance anti-amyloid immunotherapies in Alzheimer’s disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in France
Revue Neurologique. 2022-11-01.
10.1016/j.neurol.2022.08.002 -
Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort
Neurology. 2022-10-19. : 10.1212/WNL.0000000000201479.
10.1212/wnl.0000000000201479 -
High-clearance anti-amyloid immunotherapies in Alzheimer’s disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
Revue Neurologique. 2022-09-01.
10.1016/j.neurol.2022.06.012 -
Structural progression of Alzheimer’s disease over decades: the MRI staging scheme.
Brain Communications. 2022-04-28. 4(3)
10.1093/braincomms/fcac109 -
Hippocampal‐amygdalo‐ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models
Human Brain Mapping. 2022-04-07.
10.1002/hbm.25850 -
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis
Neurobiology of Disease. 2021-12-01. 160 : 105533.
10.1016/j.nbd.2021.105533 -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
Front. Bioeng. Biotechnol.. 2021-11-15. 9
10.3389/fbioe.2021.762209 -
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment
Neurobiology of Aging. 2021-11-01. 107 : 53-56.
10.1016/j.neurobiolaging.2021.07.009 -
US Food and Drug Administration Approval of Aducanumab—Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?
JAMA Neurol. 2021-09-13.
10.1001/jamaneurol.2021.3126 -
Why and how evaluating driving abilities in patients with neurodegenerative diseases?
Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 2021-06-01. 19(2) : 191-201.
10.1684/pnv.2021.0933 -
Distinct Hippocampal Subfields Atrophy in Older People With Vascular Brain Injuries
Stroke. 2021-03-04.
10.1161/STROKEAHA.120.031743 -
Clinical relevance of brain atrophy subtypes categorization in memory clinics
Alzheimer's & Dementia. 2020-12-15. 17(4) : 641-652.
10.1002/alz.12231 -
Dynamique de l’atrophie des sous-champs hippocampiques dans le vieillissement et la maladie d’Alzheimer.
Revue Neurologique. 2020-09-01. 176 : S2.
10.1016/j.neurol.2020.01.054 -
Differential annualized rates of hippocampal subfields atrophy in aging and future Alzheimer’s clinical syndrome.
Neurobiology of Aging. 2020-06-01. 90 : 75-83.
10.1016/j.neurobiolaging.2020.01.011 -
Subjective cognitive and non‐cognitive complaints and brain MRI biomarkers in the MEMENTO cohort
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2020-01-01. 12(1)
10.1002/dad2.12051 -
A Spatial Decision Eye-Tracking Task in Patients with Prodromal and Mild Alzheimer’s Disease
JAD. 2019-09-17. 71(2) : 613-621.
10.3233/JAD-190549 -
Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer’s clinical syndrome
Neurobiology of Aging. 2019-07-01. 79 : 22-29.
10.1016/j.neurobiolaging.2019.03.006 -
Acute toxic limbic encephalopathy following glyphosate intoxication
Neurology. 2019-02-08. : 10.1212/WNL.0000000000007115.
10.1212/wnl.0000000000007115 -
White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis
Mult Scler. 2019-02-07. : 135245851982829.
10.1177/1352458519828297 -
Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome
Front. Neurol.. 2018-10-11. 9
10.3389/fneur.2018.00824 -
Anatomical predictors of cognitive decline after subthalamic stimulation in Parkinson’s disease
Brain Struct Funct. 2018-05-07. 223(7) : 3063-3072.
10.1007/s00429-018-1677-2 -
Deciphering the microstructure of hippocampal subfields with in vivo DTI and NODDI: Applications to experimental multiple sclerosis
NeuroImage. 2018-05-01. 172 : 357-368.
10.1016/j.neuroimage.2018.01.061 -
Regional hippocampal vulnerability in early multiple sclerosis: Dynamic pathological spreading from dentate gyrus to CA 1
Hum. Brain Mapp.. 2018-01-13. 39(4) : 1814-1824.
10.1002/hbm.23970 -
Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric study
Journal of the Neurological Sciences. 2017-11-01. 382 : 148-154.
10.1016/j.jns.2017.10.008 -
Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
PLoS ONE. 2017-08-08. 12(8) : e0182479.
10.1371/journal.pone.0182479 -
Pattern separation performance is decreased in patients with early multiple sclerosis.
Brain Behav. 2017-06-21. 7(8) : e00739.
10.1002/brb3.739 -
Selective dentate gyrus disruption causes memory impairment at the early stage of experimental multiple sclerosis.
Brain, Behavior, and Immunity. 2017-02-01. 60 : 240-254.
10.1016/j.bbi.2016.11.010 -
Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2016-10-27. 88(2) : 146-151.
10.1136/jnnp-2016-313867 -
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler. 2016-10-25. 23(9) : 1214-1224.
10.1177/1352458516675750 -
Who Performs Lumbar Puncture, How Many Do They Perform, How and Why? A Retrospective Study of 6,594 Cases
Eur Neurol. 2016-01-01. 76(1-2) : 8-11.
10.1159/000447452 -
Cognitive impairment in a population-based study of patients with multiple sclerosis: Differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis
Eur J Neurol. 2015-04-22. 23(2) : 282-289.
10.1111/ene.12715 -
An unusual case of CSF leak following post-traumatic rupture of a sacral meningeal cyst.
Cephalalgia. 2015-01-08. 35(12) : 1130-1132.
10.1177/0333102414566202 -
Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies
Cerebellum. 2013-11-12. 13(3) : 318-322.
10.1007/s12311-013-0534-3 -
Sturge-Weber syndrome with late onset hemiplegic migraine-like attacks and progressive unilateral cerebral atrophy
Cephalalgia. 2013-09-17. 34(1) : 73-77.
10.1177/0333102413505237 -
Relevance of SOX17 Variants for Hypomyelinating Leukodystrophies and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
Annals of Human Genetics. 2012-02-20. 76(3) : 261-267.
10.1111/j.1469-1809.2011.00702.x